Literature DB >> 24436345

Will a randomized trial of unruptured brain arteriovenous malformations change our clinical practice?

L Pierot, J Fiehler, C Cognard, M Söderman, L Spelle.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24436345      PMCID： PMC7964743          DOI： 10.3174/ajnr.A3867

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  4 in total

1.  Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO).

Authors:  L Pierot; C Cognard; D Herbreteau; H Fransen; W J van Rooij; E Boccardi; A Beltramello; N Sourour; K Kupcs; A Biondi; A Bonafé; W Reith; A Casasco
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

2.  Combined treatment of brain AVMs with use of Onyx embolization followed by radiosurgery.

Authors:  L Pierot; K Kadziolka; F Litré; P Rousseaux
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-07       Impact factor: 3.825

3.  Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients.

Authors:  Juha A Hernesniemi; Reza Dashti; Seppo Juvela; Kristjan Väärt; Mika Niemelä; Aki Laakso
Journal:  Neurosurgery       Date:  2008-11       Impact factor: 4.654

4.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321
  4 in total
  6 in total

1.  Seizure predictors and outcome after Onyx embolization in patients with brain arteriovenous malformations.

Authors:  Baorui Zhang; Xin Feng; Fei Peng; Luyao Wang; Er Kang Guo; Yupeng Zhang; Peng Liu; Zhongxue Wu; Aihua Liu
Journal:  Interv Neuroradiol       Date:  2018-09-30       Impact factor: 1.610

2.  What neurointerventionists think about the treatment of unruptured brain arteriovenous malformations: the complexity of moving towards evidence-based treatment.

Authors:  Mayank Goyal; Johanna M Ospel; Nima Kashani; Adnan H Siddiqui; Ricardo Hanel; Mohammed Almekhlafi; René Chapot
Journal:  Neuroradiology       Date:  2020-04       Impact factor: 2.804

Review 3.  Molecular and genetic mechanisms in brain arteriovenous malformations: new insights and future perspectives.

Authors:  Sandra Vetiska; Thomas Wälchli; Ivan Radovanovic; Moncef Berhouma
Journal:  Neurosurg Rev       Date:  2022-10-11       Impact factor: 2.800

4.  Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence.

Authors:  Alexandra Kilian; Marianne S Clancy; Scott Olitsky; James R Gossage; Marie E Faughnan
Journal:  Vasc Med       Date:  2020-12-29       Impact factor: 3.239

5.  Treatment of Brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial.

Authors:  Tim E Darsaut; Elsa Magro; Jean-Christophe Gentric; André Lima Batista; Chiraz Chaalala; David Roberge; Michel W Bojanowski; Alain Weill; Daniel Roy; Jean Raymond
Journal:  Trials       Date:  2015-11-04       Impact factor: 2.279

Review 6.  Updates in arteriovenous malformation management: the post-ARUBA era.

Authors:  James Feghali; Judy Huang
Journal:  Stroke Vasc Neurol       Date:  2019-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.